Similar articles

• Prophylaxis of cytomegalovirus infection in renal transplantation.

  Ostermann M, MacPhee I, Chang R. Ostermann M, et al. Nephrol Dial Transplant. 2001 Nov;16(11):2276-9. doi: 10.1093/ndt/16.11.2276. Nephrol Dial Transplant. 2001. PMID: 11682689 No abstract available.
• Cytomegalovirus prophylaxis by ganciclovir followed by high-dose acyclovir in renal transplantation: a randomized, controlled trial.

  Pouteil-Noble C, Megas F, Chapuis F, Bosshard S, Colin C, Hadj-Aissa A, Pozet N, Martin X, Lefrançois N, Garnier JL, Aymard M, Touraine JL. Pouteil-Noble C, et al. Transplant Proc. 1996 Oct;28(5):2811. Transplant Proc. 1996. PMID: 8908072 Clinical Trial. No abstract available.
• The renal safety of high doses of valacyclovir for prevention of cytomegalovirus infection after renal transplantation.

  Le Meur Y, Mons S, Moesch C, Leroux-Robert C. Le Meur Y, et al. Nephrol Dial Transplant. 2000 Mar;15(3):442. doi: 10.1093/ndt/15.3.442. Nephrol Dial Transplant. 2000. PMID: 10692544 No abstract available.
• Prophylaxis of cytomegalovirus infection in renal transplantation: new data for an old problem.

  Kuypers DR, Vanrenterghem YF. Kuypers DR, et al. Nephrol Dial Transplant. 1999 Oct;14(10):2304-8. doi: 10.1093/ndt/14.10.2304. Nephrol Dial Transplant. 1999. PMID: 10528649 Review. No abstract available.
• The efficacy and cost-effectiveness of valacyclovir in cytomegalovirus prevention in solid organ transplantation.

  Reischig T, Kacer M. Reischig T, et al. Expert Rev Pharmacoecon Outcomes Res. 2014 Dec;14(6):771-9. doi: 10.1586/14737167.2014.965157. Epub 2014 Sep 25. Expert Rev Pharmacoecon Outcomes Res. 2014. PMID: 25252996 Review.